Goldman Sachs Starts New Oriental Education (EDU) at Neutral
Tweet Send to a FriendGet Alerts EDU Hot Sheet
Price: $18.99 +0.80%
Rating Summary:
8 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
8 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade EDU Now!
Goldman Sachs initiates coverage on New Oriental Education (NYSE: EDU) with a Neutral. PT $20.00.
The firm comments, "We believe EDU has taken a number of constructive steps to cooperate with the SEC in its ongoing investigation of EDU's VIE structure, and we also believe the likelihood of a negative conclusion from the investigation has been reduced."
For an analyst ratings summary and ratings history on New Oriental Education click here. For more ratings news on New Oriental Education click here.
Shares of New Oriental Education closed at $18.51 yesterday, with a 52 week range of $9.41-$29.19.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm comments, "We believe EDU has taken a number of constructive steps to cooperate with the SEC in its ongoing investigation of EDU's VIE structure, and we also believe the likelihood of a negative conclusion from the investigation has been reduced."
For an analyst ratings summary and ratings history on New Oriental Education click here. For more ratings news on New Oriental Education click here.
Shares of New Oriental Education closed at $18.51 yesterday, with a 52 week range of $9.41-$29.19.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Goldman Sachs Upgrades Ruckus Wireless (RKUS) to Buy, 'Pullback Creates Opportunity'
- UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17
- WallachBeth Capital Starts Globus Medical (GMED) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Goldman SachsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

